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Introduction 
Juniperus phoenicea L. (Family: Cupressaceae) is a well-
known Libyan medicinal plant, which has been used in 
Libyan traditional medicine for centuries for the treatment 
of various human ailments including tumours and 
cancers. In fact, in Egypt around 1500 BC was the first 
recorded use of using the Juniperus phoenicea 
medicinally, which was to relieve joint and muscle pain. 
This plant is used in folk medicine to treat rheumatism, 
gout, oedema, diarrhoea, poor appetite and urinary tract 
diseases. It is also reported to eliminate gastrointestinal 
bacteria and parasites.1,2 There are some reports on its use 
as a female contraceptive by some tribes.1 The juniper 
berry was studied as a possible treatment for diet 
controlled diabetes mellitus.3  
Several compounds, i.e., terpenoids (monoterpenes: 
predominantly α-pinene, α-phyllandrene and δ-3-carene; 
sesquiterpenes: mainly δ-cadinene; diterpenes), phenolics 
(e.g., flavonoids and biflavones, phenylpropanoids and 
lignans), furanone glycosides, hydrocarbons, and sterols, 
have been isolated from the leaves and berries of J. 
phoenicea grown in different countries.4-8 
Podophyllotoxin and deoxypodophyllotoxin were also 
found in the aerial parts of many Juniperus species 
including J. phoenicea.9  
Various biological activities for J. phoenicea have been 
reported to date. The essential oils from this plant 
exhibited moderate antibacterial and antifungal 
activities.5-8,10-13  Elmhdwi et al.14 demonstrated that the 
extracts from J. phoenicea had antibacterial activity 
against both Gram-positive and Gram-negative bacteria 
including multiple-drug-resistant (MDR) strains. This 
activity was attributed to the abundance of α-pinene and 
the overall chemical constituents of these extracts. 
Antioxidant activity of this plant was detected using the 
ABTS radical-scavenging assay with the strongest 
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Background: The current study was undertaken to assess the cytotoxicity of the leaves of 
Libyan Juniperus phoenicea (Cupressaceae) against human cancer cell lines. 
Methods: The cytotoxicity of the n-hexane, dichloromethane (DCM) and methanol 
(MeOH) extracts of the leaves of J. phoenicea (JP), obtained from sequential Soxhlet 
extractions, was assessed against four human cancer cell lines: EJ138 (human bladder 
carcinoma), HepG2 (human liver hepatocellular carcinoma), A549 (human lung 
carcinoma) and MCF7 (human breast adenocarcinoma) using the MTT assay.   
Results: The cell line A549 was the most sensitive to the JP extracts, with the highest level 
of cytotoxicity with the IC50 values of 16, 13 and 100 µg/mL for the DCM, n-hexane and 
MeOH extracts, respectively.  However, generally the most potent cytotoxic extract across 
the other cells tested was the n-hexane extract, followed by the DCM extract, whilst the 
MeOH extracts showed little or no cytotoxicity.  The percentage of viability of cells 
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1 to 5 and 7, respectively. Fractions 4 and 5 showed the greatest effect. DCM fractions 2, 
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Conclusion: The outcome of the present study suggested that the JP leaves possess 
cytotoxic activities. The high level of cytotoxicity of the n-hexane and DCM extracts 
suggested that lipophilicity might affect the cytotoxicity of JP, where the less polar  
compounds had the strongest cytotoxicity.  
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antioxidant effect being found with the MeOH extract.6 
The aqueous extract of J. phoenicia showed anti-
diarrhoeal effect in vivo on experimental rat models of 
diarrhoea by reducing intestinal fluid accumulation and 
inhibiting intestinal motility.2  Akkol et al.15 revealed 
remarkable anti-inflammatory and antinociceptive 
activities of five Juniperus species. Cairnes & Ekundayo9 
showed that the ethanolic extract of J. phoenicea twigs 
and leaves and two isolated compounds, 
desoxypodophyllotoxin and p-peltatin-methyl ether, were 
cytotoxic in the KB cell cultures (human cervix 
carcinoma). A MeOH extract of J. phoenicea from Saudi 
Arabia and Indonesia displayed high cytotoxicity in Vero 
(normal monkey kidney) and HEP-2 (human laryngeal 
carcinoma) cell lines.16 In addition, this plant also 
displayed significant cytotoxicity against both MCF7 
(human breast adenocarcinoma) and HCT-116 (human 
colon carcinoma) cell lines.1  
As a part of our continuing phytochemical and bioactivity 
studies on Libyan medicinal plants,17-22 we now report on 
the cytotoxicity of the extracts and fractions of the leaves 
of J. phoenicea growing in Libya against four human 
cancer cell lines: human bladder carcinoma cell line 
(EJ138), human hepatocellular carcinoma cell line 
(HepG2), human lung carcinoma cell line (A549) and 
human breast adenocarcinoma cell line (MCF7).  
 
Materials and Methods 
Plant material 
The leaves of Juniperus phoenicea L. were collected from 
Al-Jabal Al Akhdar, Libya, in 2013. The plant material 
was identified at the Faculty of Science Herbarium, 
Tripoli-Libya, and a voucher specimen (no. D68122) has 
been retained there.  Leaves of this plant were air-dried, 
powdered and kept in a tightly closed amber coloured 
container for subsequent studies. 
 
Extraction  
Ground leaves of J. phoenicea (86.5 g) were Soxhlet-
extracted, sequentially, with n-hexane, DCM and MeOH, 
800 mL each.  Ten cycles were allowed for each 
extraction, and the temperature of the heating mantle for 
all extractions was kept constant at 60°C. The extracts 
were filtered and evaporated to dryness using a rotary 
evaporator at a temperature not exceeding 45°C under 
reduced pressure.  All extracts were stored at 4°C.   
 
Fractionation techniques  
The crude extracts of J. phoenicea leaves were separated 
into various fractions using vacuum liquid 
chromatography (VLC) on silica gel for the n-hexane and 
DCM extracts, and solid-phase extraction (SPE) on 
reversed-phase C18 silica for the MeOH extract.23,24. The 
n-hexane extract (4.6 g) was fractionated by VLC eluting 
with n-hexane-ethyl acetate mixtures of increasing 
polarity to yield seven fractions: F1: 82.5 mg, F2: 555 mg, 
F3: 998.7 mg, F4: 655.5 mg, F5: 118.8 mg F6: 22.1 mg, 
F7: 103.7 mg.  Similarly, the DCM extract (1.289 g) was 
fractionated by VLC, starting elution with n-hexane-
DCM mixtures, then increasing polarity with MeOH to 
yield eight fractions: F1: 15 mg, F2: 20 mg, F3: 41 mg, 
F4: 134 mg, F5: 128.5 mg F6: 9.3 mg, F7: 2.7 mg and F8: 
2.4 mg. The dried MeOH extract (1.4 g) was re-suspended 
in 10% MeOH in water, and subjected to solid phase 
extraction (SPE) using a cartridge (20 g) pre-packed with 
reversed-phase silica C18 (ODS). A step gradient was 
applied starting with 20% MeOH in water, then 50%, 80% 
and 100% MeOH in water (200 mL each).  Four fractions 
were collected: F1: 895 mg, F2: 135 mg, F3: 54 mg, F4: 
25 mg, and these fractions were dried using a rotary 
evaporator and a freeze dryer.    
 
MTT assay 
The cytotoxic activity of the n-hexane, DCM and MeOH 
extracts of J. phoenicea were assessed against EJ138 
(human bladder carcinoma), HepG2 (human liver 
hepatocellular carcinoma), A549 (human lung carcinoma) 
and MCF7 (human breast adenocarcinoma) cell lines. In 
addition, fractions obtained from n-hexane, DCM and 
MeOH extracts of J. phoenicea were also assessed for 
cytotoxicity against the cell line A549, as the extracts 
showed the highest level of activities against this cell line. 
The cells were seeded into 24-well plates (5 x 104 
cells/well) and incubated under 5% CO2, 95% humidity at 
37oC for 24 h. The different extracts or isolated fractions 
were diluted in medium containing DMSO (0.01% (v/v) 
(including the negative control), to achieve extract 
concentrations of (0, 0.8, 4, 20, 100 and 500 µg/mL) or 
isolated fraction concentrations of (0, 0.4, 2, 10, 50 and 
250 µg/mL). These doses were then used to treat the cells 
for 24 h before assessment using the MTT assay25 
following the standard protocol. Briefly, each treatment 
was removed from the 24-well plates of cells and replaced 
with MTT solution (0.5 mg/mL MTT in medium (1 
mL/well)). The cells were then incubated under 5% CO2, 
95% humidity at 37oC for 2 h. The MTT solution was then 
removed from each well of cells and replaced with 
isopropanol (0.5 mL/well) to lyse the cells, and to release 
and solubilise the blue formazan product. The absorbance 
reading (540 nm) of lysates from treated cells in each well 
on each occasion was recorded and was expressed as a 
percentage of the mean value of the control absorbance on 
each occasion. The results for each treatment and dose 
derived from at least 12 wells (n≥12) from three or more 
separate occasions. To determine IC50 values, data were 
presented in EXCEL graphs with the dose value (µg/mL) 
on the X-axis on a log10 scale and the % viability 
compared to control on the Y-axis. The IC50 values are 
determined from the trend line of the data points. 
 
Statistical analysis 
All experiments were carried out in triplicate on separate 
occasions. Data were expressed as means ± standard error 
of the mean. The graphs were plotted using nonlinear 
regression with the use of Microsoft Excel version 2013. 
 
Results and Discussion   
In the present study, the cytotoxic effect of J. phoenicea 
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leaf extracts against four human cancer cell lines, MCF7, 
HepG2, EJ138 and A549, was determined using the MTT 
assay. Although cytotoxicity of J. phoenicea against 
MCF7 was reported previously,4 to the best of our 
knowledge, this is the first report on the assessment of 
cytotoxicity of J. phoenicea   J. phoenicea leaf extracts 
and fractions against HepG2, EJ138 and A549 cell lines.  
The extracts of J. phoenicea showed the highest level of 
cytotoxic activity against the human lung 
adenocarcinoma cell line A549 with the IC50 values of 16, 
13 and 100 µg/mL, respectively, for the n-hexane, DCM 
and MeOH extracts (Table 1). Whilst the DCM extract 
appeared to be the most cytotoxic extract against the A549 
cells, the n-hexane extract was the most cytotoxic across 
the board against HepG2, EJ138 and MCF7 having 
respective IC50 values of 10, 40 and 14 µg/mL. The DCM 
extract also resulted in cytotoxicity in all cell lines tested 
with IC50 values of 50 µg/mL for EJ138 cells, 42 µg/mL 
for HepG2 cells, 16 µg/mL for MCF7 cells and 13 µg/mL 
for A549 cells. The MeOH extract showed low-level of 
cytotoxicity in EJ138 (IC50 130 µg/mL), HepG2 (IC50 900 
µg/mL), A549 (IC50 100 µg/mL) and MCF7 (IC50 >1000 
µg/mL) (Table 1). According to Sahranavard et al,26 plant 
extracts are only considered to be cytotoxic to cells if the 
IC50 value is <100 μg/mL, therefore these MeOH extract 
results were regarded as non-cytotoxic to each of the cell 
lines tested. The higher level of cytotoxic activity of the 
n-hexane and DCM extracts suggested that lipophilicity 
might have an impact on the cytotoxic activity of J. 
phoenicea, where the less polar (high lipophilic) 
compounds showed the strongest cytotoxic effect. 
However, it is known that lipophilicity is one of the major 
factors that influences the transport, absorption, and 
distribution of chemicals in biological systems. 
Bioassay-guided phytochemical and biological 
fractionation is an approach whereby a crude extract of 
plant is fractionated and re-fractionated, continually 
monitored fractions by appropriate bioassay(s), until a 
pure biologically active fraction/compound is found.24 To 
adopt this approach, n-hexane, DCM and MeOH extracts 
were further fractionated by two different techniques: 
solid-phase extraction for MeOH extract and VLC for the 
n-hexane and DCM extracts to get different fractions 
(four fractions from MeOH extract, seven fractions from 
n-hexane extract and eight fractions from DCM extract). 
All fractions were tested for cytotoxicity against the A549 
cell line, as these cells appeared to be the most sensitive 
to the all three extracts. Taken that IC50 values >100 
μg/mL are considered as non-cytotoxic, n-hexane 
fractions 1 (F1) and 6 (F6), DCM fractions 1, and 5 to 8 
(F1, F5, F6, F7 and F8) and MeOH fractions 1 and 2 (F1 
and F2) were all regarded as non-cytotoxic in the A549 
cells. However, n-hexane fractions 2 to 5 and 7 (F2, F3, 
F4, F5 and F7) were cytotoxic. In addition, DCM 
fractions 2 to 4 (F2, F3 and F4) and MeOH fractions 3 and 
4 (F3 and F4) were also considered cytotoxic (Table 2). 
The most potent fractions appear to be n-hexane fraction 
5 (F5) with an IC50 value of 10 µg/mL and DCM fraction 
4 (F4) with an IC50 value of 19 µg/mL. 
Whilst the MeOH fraction 1 (F1), which was the most 
polar fraction of all, was found to be non-cytotoxic, an 
interesting observation was that doses 2, 10 and 50 µg/mL 
did appear to trigger proliferation in the A549 cells with 
approximately a 20% increase in viability compared to the 
control (0 µg/mL) (Figure 1). However, further 
interrogation of these data indicated that only the 50 
µg/mL dose resulted in a statistically significant 
difference compared to the control (P<0.05).  There was 
high variability in the data resulting from fraction 1 (F1), 
and this might have contributed to this anomaly. 
Several phytochemicals, e.g., alkaloids, flavonoids, 
lignans, phenols, steroids and terpenes have been 
demonstrated to possess prominent cytotoxic properties 
against cancer cells.27 
Notably, all these groups of phytochemicals have 
previously been isolated from the leaves and berries of J. 
phoenicea and other Juniperus species grown in different 
countries.9,28-30 Podophyllotoxin, which is also present in 
J. phoenicea at a low level,31 is a well-known cytotoxic 
compound against cancer cell lines. Its cytotoxicity is 
mediated by inhibition of microtubule formation and this 
compound serves as a unique starting compound for the 
semisynthesis of anticancer drugs that are known to 
inhibit topoisomerase II such as etoposide, teniposide, or 
etopophos.31 
 
 Table 1. The IC50 (µg/mL) of n-hexane, DCM and MeOH extracts of J. phoenicea on a selection of four cancer cell lines. 
Cell type IC50 values (µg/mL)  
n-Hexane DCM MeOH 
Human bladder carcinoma cells (EJ138) 40 50 130 
Human hepatocellular carcinoma cells (HepG2) 10 42 900 
Human lung carcinoma cells (A549) 16 13 100 
Human breast adenocarcinoma cells (MCF7) 14 16 > 1000 
The IC50 values for the n-hexane, DCM and MeOH extracts of J. phoenicea different on the cell lines of four different 
cancer types.  Values greater than 100 µg/mL were considered as non-cytotoxic. 
 
Table 2. The IC50 (µg/mL) of n-hexane, DCM and MeOH fractions of J. phoenicea fractions on A549 (human lung carcinoma) cells. 
Extracts IC50 values (mg/mL) of the fractions 
F1 F2 F3 F4 F5 F6 F7 F8 
n-Hexane 160 62 90 30 9.5 >1000 40 NA 
DCM >1000 60 92 19 >1000 >1000 >1000 >1000 
MeOH >1000 244 50 85 NA NA NA NA 
The IC50 values for the n-hexane, DCM and MeOH fractions of J. phoenicea on A549 human lung carcinoma cells. Values greater than 100 
µg/mL were considered as non-cytotoxic. NA = Not applicable. 
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Figure 1. The cytotoxic activity of J. phoenicea MeOH fraction 1 
(F1) against A549 human lung carcinoma cell line. The asterisk * 
indicates a significant difference when compared to control 
(P<0.05) and ns indicates no significant difference to control. The 
results are mean values ±SEM derived from n≥12 from three 
separate occasions.  
 
Ren et al.32 detailed the anticancer effects of the 
flavonoids, which were shown to inactivate carcinogen, 
inhibit proliferation, arrest the cell cycle, induce apoptosis 
and differentiate, inhibit angiogenesis, prevent oxidation 
and reverse multidrug resistance. Previous studies had 
shown that many flavonoids and polyphenolic 
compounds were present in some Juniperus species.33-35  
 
Conclusion 
The outcome of the present study suggested that the J. 
phoenicea leaves possess cytotoxic activities. The high 
level of cytotoxic activities of the n-hexane and DCM 
extracts suggested that lipophilicity might affect the 
cytotoxic activity of J. phoenicea, where the less polar 
(high lipophilic) compounds might have the strongest 
cytotoxic effect.  As terpenes are the main lipophilic 
compounds previously reported from less polar extracts 
and essential oils of J. phoenicea, it is reasonable to 
assume that the cytotoxicity observed with the less polar 
extracts was contributed by various cytotoxic terpenes as 
well as the lignans, podophyllotoxin and 
deoxypodophyllotoxin. 
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